BioCentury
ARTICLE | Clinical News

BRCA1 and BRCA2 breast and ovarian cancer genes regulatory update

May 21, 2001 7:00 AM UTC

Myriad Genetics Inc. (MYGN), Salt Lake City, Utah Product: BRCA1 and BRCA2 breast and ovarian cancer genes Business: Pharmacogenetics MYGN received eight patents covering the use of BRCA1 and BRCA2 ...